{"response": {"meta": {"time": 29, "hits": 1, "offset": 0}, "docs": [{"news_desk": "Business/Financial Desk", "document_type": "article", "_id": "4fd20cf38eb7c8105d77c8b4", "headline": {"kicker": "THE MEDIA BUSINESS: ADVERTISING -- ADDENDA", "main": "Units of Lowe Group Will Introduce Drug"}, "pub_date": "1996-12-02T00:00:00Z", "slideshow_credits": null, "source": "The New York Times", "byline": {"original": "By Stuart Elliott", "person": [{"lastname": "Elliott", "rank": 1, "firstname": "Stuart", "organization": "", "role": "reported"}]}, "abstract": "Roche Laboratories formally names various units of Lowe Group in New York to introduce Xenical, anti-obesity drug (S)", "web_url": "http://www.nytimes.com/1996/12/02/business/units-of-lowe-group-will-introduce-drug.html", "section_name": "Health; Business", "lead_paragraph": "Roche Laboratories in Nutley, N.J., has formally named various units of Lowe Group in New York to introduce Xenical, an anti-obesity drug, with direct marketing and other advertising. Billings were estimated to be as much as $50 million. The account had originally been assigned to Lowe in October. But after five former top executives of the Lowe Direct unit of Lowe left to open their own breakaway shop, there was speculation that Roche might move Xenical to the new shop, Lieber, Levett, Koenig, Farese & Babcock in New York.", "snippet": "Roche Laboratories in Nutley, N.J., has formally named various units of Lowe Group in New York to introduce Xenical, an anti-obesity drug, with direct marketing and other advertising. Billings were estimated to be as much as $50 million.    The...", "blog": [], "keywords": [{"value": "LOWE GROUP", "name": "organizations"}, {"value": "ROCHE LABORATORIES", "name": "organizations"}, {"value": "WEIGHT", "name": "subject"}, {"value": "OBESITY", "name": "subject"}, {"value": "XENICAL (DRUG)", "name": "subject"}], "print_page": "11", "type_of_material": "News", "word_count": 138, "subsection_name": null, "multimedia": []}]}, "status": "OK", "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}